KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Herbalife (HLF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Herbalife (HLF) over the last 17 years, with Q3 2025 value amounting to $305.5 million.

  • Herbalife's Cash & Equivalents fell 2689.64% to $305.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $305.5 million, marking a year-over-year decrease of 2689.64%. This contributed to the annual value of $415.3 million for FY2024, which is 3026.03% down from last year.
  • Per Herbalife's latest filing, its Cash & Equivalents stood at $305.5 million for Q3 2025, which was down 2689.64% from $320.9 million recorded in Q2 2025.
  • In the past 5 years, Herbalife's Cash & Equivalents ranged from a high of $846.3 million in Q2 2021 and a low of $305.5 million during Q3 2025
  • Its 5-year average for Cash & Equivalents is $510.6 million, with a median of $516.3 million in 2022.
  • As far as peak fluctuations go, Herbalife's Cash & Equivalents tumbled by 5158.74% in 2021, and later surged by 1533.99% in 2023.
  • Quarter analysis of 5 years shows Herbalife's Cash & Equivalents stood at $610.4 million in 2021, then dropped by 15.42% to $516.3 million in 2022, then rose by 15.34% to $595.5 million in 2023, then plummeted by 30.26% to $415.3 million in 2024, then dropped by 26.44% to $305.5 million in 2025.
  • Its Cash & Equivalents was $305.5 million in Q3 2025, compared to $320.9 million in Q2 2025 and $329.4 million in Q1 2025.